News in 1 Shot (September 2012)

Summary of WPPF News Update

Topic News

*

World Pharmacists Day 25 September

1.

FIP Annual report 2011-2012

2.

[WHO]: News Update

3.

The sustainability of the supply chain – lessons from the EU

4.

PSA, Indonesian Pharmacists Association in strategic alliance

 

 

News

1.

FIP News 11 September 2012

2.

[WHO – RMNCH News 2012 ]: September

3.

[NPS]: Update September

4.

FDA Actively Promotes the “Industrial Consultation and Guidance for Regulatory Science on Drugs and Medical Devices”

5.

Scholarships help Aboriginal and Torres Strait Islander pharmacy students

6.

Pharmacy Business Network delivers the goods

7.

PSA’s CPExpo returns in 2013

8.

National Student Business Plan winners announced

9.

Community Pharmacy – Be a leader of innovation

10.

Pharmacy of the Year 2013 – in search of excellence!

 

 

International

1.

WHO-WHO Drug InformationVolume 26, N° 3, 2012

2.

WHO-WHO Pharmaceuticals NewsletterNo. 4, 2012

 

 

Publication

1.

FIP Annual report 2011-2012

 

 

Upcoming Event

1.

27.08.2012 – 04.10.2012 
Annual meetings of WHO Regional Committees

2.

26.09.2012 – 27.09.2012 
Evidence-Based Medicine & Critical Appraisal in Making Choices & Formulary Drug Listing

3.

28.09.2012 
World Rabies Day

4.

29.09.2012 
World Heart Day

5.

29.09.2012 – 30.09.2012 
22nd Singapore Pharmacy Congress

 

 

Campaign

1.

THE LANCET: Special release to mark opening of United Nations Assembly

2.

Press release: $20 Billion for Women’s and Children’s Health

3.

UN September 2012: In focus

4.

PMNCH/FIGO: Progress towards MCH MDGs 4 & 5 

5.

Women Deliver President Jill Sheffield calls for focus on women in fight against chronic diseases

6.

Preparatory Meeting of 2013 Third Global Forum on Human Resources for Health  

 

 

Public Health

1.

Turkey marks progress in fight against noncommunicable diseases
September 2012

2.

23 September 2012 
Novel Coronavirus infection in the United Kingdom

3.

18 September 2012
Cholera in Sierra Leone – update

4.

18 September 2012
Ebola outbreak in Democratic Republic of Congo – upd

5.

14 September 2012
Ebola outbreak in Democratic Republic of Congo – upd

 

 

Pharmacy Education E-learning

1.

Practice Review — type 2 diabetes priorities and targets

2.

Nurse Update September 2012

 

 

WPPF in FIP Showcase – Centennial Congress

Reference: WPPF Satelitte Secretariat

WPPF-2012-Poster

World Pharmacists Day 25 September

Reference:  

https://www.fip.org/www/index.php?page=latest_news&news=newsitem&newsitem=133

World Pharmacists Day 25 September

As designated by the FIP Council several years ago at the FIP Congress in Istanbul, 25 September marks the annual World Pharmacists Day. For this day, FIP is encouraging the world’s pharmacists to organise activities that promote and advocate for the role of the pharmacist in improving health in every corner of the world. 

This year the theme of World Pharmacists Day is Pharmacists – your partners in using medicines responsibly, which directly complements the theme of the upcoming FIP Centennial Congress and coinciding Summit for Ministers of Health on the Added Value of Responsible Medicines Use.  

Show the world how pharmacists can help everyone use medicines to their healthiest potential!

FIP News 11 September 2012

Reference:  

http://fip.a1.mailplus.nl/genericservice/code/servlet/React?encId=jXCpi6ez8YmwFHD&actId=107650&command=openhtml

Click here to view the online version
Newsletter for Member Organisations
11 September 2012
Message from the FIP President, Dr Michel Buchmann

Many of FIP member organisations have expressed their emotion further to the sad passing of our General Secretary and CEO, Ton Hoek on 28 July 2012.

I would like to thank you all on behalf of the FIP Executive Committee for your kind messages which have been shared with his family.

At its August meeting, the FIP ExCo decided that for the interim period (time needed to find and recruit the successor of Ton), the following distribution of roles and responsibilities is established:

Luc Besançon, currently Manager Professional and Scientific Affairs, will be during the interim period, Acting General Secretary for Professional, Scientific and External Affairs

Rachel van Kesteren, currently Executive Secretary, will be during the interim period, Assistant for Financial and Personnel Affairs

Carola van der Hoeff, currently Congress Director, will be during the interim period, Acting General Secretary for Administrative and Internal Affairs

As ExCo we recognize the exceptional efforts made by the staff members during these very demanding times. 

BPP Investigation and Analysis of Ethics and Professional Autonomy in Pharmacy: Exploring your views
Dear FIP Colleague

Earlier this year, the Board of Pharmaceutical Practice launched a Working Group on Pharmacist Ethics and Professional Autonomy.

Professional autonomy in pharmacy practice is a growing concern in the profession worldwide, for many reasons and in many different ways.

We are exploring this issue on a global basis and need your perspective. We kindly invite you to complete the short questionnaire consisting of fewer than 10 closed-ended questions and available here.

It would be very helpful if you could spare a few minutes to fill out this survey before 1 October 2012. We thank you for your time and valuable input.

The BPP Working group on Ethics and Professional Autonomy. 

  Contacting fip  
PO Box 84200
2508 AE The Hague
The Netherlands

Tel.: +31-70-3021970
Fax: +31-70-3021999
Email: fip@fip.org
  Like us!


  Reminder – visit the FIP website for all the latest news and benefits for Member Organisations!  
FIP endeavors to constantly update and expand our website – check back frequently news and updates from FIP and around the world. 


  Did you know  
FIP is the global federation of national associations representing 2 million pharmacists and pharmaceutical scientists around the world.
To change your contact information or to unsubscribe, please use thislink.
Here you can also change your preferences.
 

[WHO]: News Update

Reference:  

WHO news

Success in Turkey’s fight against noncommunicable diseases

21 September 2012 — Just six years ago, more than one in three adults in Turkey used tobacco products, which greatly increase the risk of noncommunicable diseases such as cardiovascular disease, lung cancer, and chronic respiratory disease. But today Turkey is a success story. A new study of health professionals showing that more than 1 in 2 Turkish health managers have given up tobacco in the past 4 years, reflects what is being seen across the country.

Accelerating progress on child survival

13 September 2012 — The pace of reducing child deaths has accelerated sharply since 2000, according to new data released today by UNICEF, WHO, the World Bank and the UN Population Division. An annual report by the UN Inter-agency Group for Child Mortality Estimation shows that in 2011, an estimated 6.9 million children died before their fifth birthday, compared to around 12 million in 1990.

Europe assesses monitoring of noncommunicable diseases

18 September 2012 — Governments are deciding on the best targets and indicators to monitor noncommunicable diseases (NCDs) such as heart disease, stroke, cancer, diabetes and chronic lung disease. Signs of progress could include a reduction in deaths or risk factors such as tobacco, healthy diet and physical activity. But it is critical to ensure that the markers of progress can be measured. Countries in WHO’s European Region had a web-consultation to determine the capacities for monitoring NCDs.

Expanding prepayment key to universal health coverage

4 September 2012 — Health insurance systems hold untapped potential for achieving universal coverage of health services. A study of countries in Asia and Africa published in this month’s Bulletin of the World Health Organization, found that community and social health insurance schemes in these countries increase financial protection by reducing the need to pay for health services at the point of delivery.

Global Alert and Response (GAR)

Disease Outbreak News

Most recent news items

Features: tobacco (http://www.who.int/features/tobacco/en/)


WHO Drug Information

Volume 26, N° 3, 2012

Share

Authors:
QSM

WHO Drug Information

Publication details

Number of pages100
Publication dateSeptember 2012
LanguagesEnglish

Downloads

WHO Pharmaceuticals Newsletter

No. 4, 2012

Share

Authors:
Quality Assurance and Safety

WHO Pharmaceuticals Newsletter

Publication details

EditorsShanthi Pal
Number of pages33
Publication dateAugust 2012
LanguagesEnglish

Downloads


[WHO – RMNCH News 2012 ]: September

Reference: 

http://www.who.int/pmnch/media/news/2012/en/

September

[NPS]: Update September

Reference:

http://www.nps.org.au/health_professionals/publications/prescribing_practice_review

http://www.nps.org.au/health_professionals/publications/nurse_update

NPS Practice Review

Title Date
Practice Review — type 2 diabetes priorities and targets September 2012

NPS Nurse Update

Title Date
Nurse Update September 2012
This issue of Nurse Update looks at type 2 diabetes, the new cough and cold medicines warning for children, the Nursing Insight Group and the new medication safety online learning program.
September 2012

FDA Actively Promotes the “Industrial Consultation and Guidance for Regulatory Science on Drugs and Medical Devices”

Reference:  

https://www.fda.gov.tw/EN/newsContent.aspx?id=9179&chk=fabe39d1-dd1c-40d7-b57b-5bf18ef00afc&param=pn%3d1%26cid%3d118%26cchk%3d5bad4865-9037-437c-a198-9e673d42dd81

Since the establishment of Food and Drug Administration (FDA), Department of Health on January 1, 2010, the Executive Yuan has been dedicated to strengthening medical and pharmaceutical industrial guidance through the promotion of the “Diamond Action Plan for Biotech Takeoff”. A consultation/guidance mechanism and diamond early harvest list for drug and medical device projects are developed for the domestic research and development of new drugs and medical devices.

The project consultation and guidance mechanism for drugs includes 4 evaluation criteria – “innovativeness”, “contribution”, “early harvest” and “fulfillment of regulations”; for medical devices, items are selected based on the 4 evaluation criteria of “first of its kind in domestically produced items”, “the best among same-category products”, “new medical indication” or “industry under focal support of a national project”. The mechanism sets its goals based on the milestones of assisting the projects in reaching the pre-clinical to clinical test stage (first in human), entering the next clinical test, applying for inspection and registration, and obtaining the license.

Since the establishment of FDA, 10 products in the drug area have been guided successfully to reach the R&D milestone, with 2 items having completed the marketing application, 5 items entering the third-stage clinical test, 1 item entering the second-stage clinical test, and 2 items entering the first-stage clinical test. In terms of medical devices, the achievements include 10 items having completed marketing, and 3 items having completed the clinical test application.

In addition, FDA has also convened the initial meeting of manufacturer consultation and guidance for at least 8 projects. Through face-to-face communication with the manufacturers, FDA has understood the R&D plan and status, and proposed specific and helpful suggestions to accelerate the inspection and marketing processes for new drugs and new medical devices, so that Taiwan people may use our self-developed new products as early as possible.

The sustainability of the supply chain – lessons from the EU

Reference: 

http://www.psa.org.au/archives/14784

18 September 2012 

Recent developments in Australia’s pharmacy supply chain model have raised concerns about margins and sustainability in community pharmacies.

Australia’s concerns are not isolated, and recent developments across Europe have underscored   some of the issues being raised in this country.

The European experience will be the subject of a presentation by keynote speaker John Chave, Secretary General of the Pharmaceutical Group of the European Union which represents community pharmacists in 32 European countries, who will speak on the topic of How secure is the supply chain during one of the new business and management stream sessions on Saturday, October 20 from 1:15pm – 2:45pm, on the topic of Have you got what you need?

Mr Chave will address the issues of increased use of generics, reduced margins, the redirecting of supply chains, mail order and online pharmacies – all of which are having a major impact on traditional supply chains.

“In recent years, Europe has seen a number of evolutions in the supply chain which have raised questions over its future sustainability,” Mr Chave said.

“These include the implementation of policies to increase the uptake of generics and reduce generics prices, including tendering of generics; the increased distribution of some medicines from secondary care settings rather than community pharmacies; the increased availability of medicines from internet or mail order sources; and the adoption of direct to pharmacy distribution schemes and /or the imposition of market quotas by the pharmaceutical industry.

“Negative consequences for pharmacies have been seen in terms of declining revenues, difficulties in sourcing some medicines because of shortages and increased administration time and costs.

“The presentation will explain the ‘state of play’ of the European supply chain, the impact of recent changes on community pharmacy, and the prospects for the future.”

Mr Chave’s presentation will complement those  of Norman Thurecht who will look at The financial impact of generic pricing reforms, and Bruce Annabel who will present on Getting the product mix right.

PAC12   will be held at the Melbourne Exhibition and Convention Centre from Friday 19 October 2012 to Sunday 21 October 2012. Full program information and online registration is available at www.psa.org.au/pac

Recent developments in Australia’s pharmacy supply chain model have raised concerns ENDS

MEDIA CONTACT:                          Peter Waterman   0487 922 176

ENDS

MEDIA CONTACT:                          Peter Waterman   0487 922 176